Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quantifying Variation in Treatment Utilization for Type 2 Diabetes Across Five Major University of California Health Systems

Diabetes Care(2021)10.2337/dc20-0344Source: DataRank Database

Quantifying Variation in Treatment Utilization for Type 2 Diabetes Across Five Major University of California Health Systems is a research paper published in Diabetes Care (2021). On theSindex it has a DataRank of 0.533. It has been cited 11 times, with 7 citing works in its 1-hop citation network.

N/A

0.533DataRank · unranked

Scored on demand from live citation data

Open Access11 citations · 7 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 1.21)OA: bronzeTopics (47)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 70%Citation Network 30%

Base Score Contribution

0.373

From this paper's citation signal

Citation Network Contribution

0.161

From 7 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 7 citers.

Predicting post–liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning
American Journal of Transplantation202314 citations54 referencesContributes 0.050
Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study
Journal of Clinical Medicine20245 citations57 referencesContributes 0.031
“Beyond MELD” – Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation
Journal of Hepatology202249 citations156 referencesContributes 0.025
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
Diabetes Care202131 citations147 referencesContributes 0.024
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
Diabetes202121 citations147 referencesContributes 0.021

Authors (5)

Suneil K. Koliwad ORCID,Ayan Patel,Atul Janardhan Butte ORCID,Ayan R. Patel ORCID,Thomas A. Peterson ORCID

Live enrichment

PubMed:33531419 OpenAlex:https://openalex.org/W3128295290

National Institute of General Medical Sciences

Grant: R01 GM079719

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P30 DK098722

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01 DK112304

National Heart, Lung, and Blood Institute

Grant: K23 HL136899

National Center for Advancing Translational Sciences

Grant: UL1 TR001872

National Institutes of Health

Grant: 5R01GM079719-04

Enabling new discoveries in pharmacogenomics through a genomic date-driven nosolo

National Institutes of Health

Grant: 3R01DK112304-03S1

Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV

National Institutes of Health

Grant: 5P30DK098722-04

UCSF Nutrition Obesity Research Center

National Institutes of Health

Grant: 5UL1TR001872-02

Clinical and Translational Science Institute

National Institutes of Health

Grant: 5K23HL136899-05

Bring it Down San Francisco: Harnessing cloud-based technology to improve hypertension management in a low-income underserved population

NIDDK NIH HHS

Grant: P30 DK063720

NCRR NIH HHS

Grant: M01 RR001271

FWCI

1.21

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

bronzeLicense: https://www.diabetesjournals.org/content/license

journalhttps://diabetesjournals.org/care/article-pdf/44/4/908/632165/dc200344.pdf

publisherhttps://diabetesjournals.org/care/article-pdf/44/4/908/632165/dc200344.pdf

publisherhttp://care.diabetesjournals.org/syndication/doi/10.2337/dc20-0344

journalhttps://doi.org/10.2337/dc20-0344

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33531419

Fields of Study

Diabetes Treatment and ManagementMedication Adherence and ComplianceAdvanced Causal Inference Techniques03 medical and health sciences0302 clinical medicineDiabetes Mellitus, Type 2HumansHypoglycemic AgentsMetforminRetrospective StudiesSulfonylurea Compounds

MeSH Terms

Diabetes Mellitus, Type 2HumansHypoglycemic AgentsMetforminRetrospective StudiesSulfonylurea Compounds

Keywords

MedicineType 2 diabetesGlipizideHealth careMetforminFamily medicineCohortMedicaidMedical recordHealthcare systemGerontologyDiabetes mellitusInternal medicineBiomedical and clinical sciencesPreventionClinical SciencesDiabetes610Health sciencesHealth ServicesMedical and Health SciencesEndocrinology & MetabolismGood Health and Well BeingSulfonylurea CompoundsDiabetes Mellitus, Type 2Clinical ResearchHumansHypoglycemic AgentsType 2Retrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being